CLINICAL_TRIALS
trial_result
· 2021-05-20
Clinical Trial Update: Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC) [Phase 2]
Summary
Phase 2 trial of topical remetinostat gel as neoadjuvant therapy in squamous cell carcinoma was terminated, with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kavita Sarin | Conditions: Squamous Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2021-05-20